It is surprising how little has been done here. A failure of the pharma/academic model perhaps. I am going to write more on why biotech does not innovate as muc

It is surprising how little has been done here. A failure of the pharma/academic model perhaps. I am going to write more on why biotech does not innovate as much as it could, in another post.